Pfizer Inc (PFE)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Pfizer*s Revenue Decline Amid Cancer Treatment Advancements Raises Concerns
Pfizer Inc. Faces Financial Challenges: Revenue Crumbles in Fiscal Fourth Quarter of 2023
Pfizer Inc*s Financial Slump Continues: Profits Plunge and Revenue Falters in First Quarter of 2023
Outstanding Earnings per Share Increase by 59.3 % at the company amid the first quarter of 2022
revenue receded by -6.043 %, at PFE over the financial time-frame closing Oct 02 2022